The Osteoporosis Drugs Market To Be Backed By Technological Innovation In The Next Decade

1
The Osteoporosis Drugs Market To Be Backed By
Technological Innovation In The Next Decade
Report Id PMRREP2983 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
North America to remain dominant in the global
parenteral medical nutrition market

• However, there are various side effects and
  complications associated with osteoporosis drugs
  such as heartburn, irritable bowel syndrome,
  nausea, and ulcers in the stomach or esophagus.
  Furthermore, patent expiration of osteoporosis
  drugs also inhibits the growth of the market.The
  osteoporosis drugs market is anticipated to grow
  from an estimated US11,226.1 Mn by the end of
  2015 to account for US14,786.7 Mn by 2022 at a
  CAGR of 4.0 during the forecast period.
• In North America, the prevalence of osteoporosis
  is high primarily due to increasing geriatric
  population, growing obesity, and rising
  prevalence of lifestyle associated diseases in
  the region. According to the National
  Osteoporosis Foundation, in 2013, approximately
  54 million people in the U.S. aged 50 years and
  above were affected by osteoporosis and low bone
  mass. According to the U.S. Department of Health
  and Human Services, in the U.S., approximately
  250,000 hip fractures are associated with
  osteoporosis.
• In Europe, increasing aging population, changing
  lifestyles, and increasing consumer awareness
  about osteoporosis care are driving the growth of
  the osteoporosis drug market. According to the
  International Osteoporosis Foundation,
  approximately 5.5 million men and 22 million
  women suffered from osteoporosis in 2010.
  Moreover, according to International Osteoporosis
  Foundation, approximately 27.5 million people in
  Europe suffered from osteoporosis in 2010 and the
  number is expected to reach 33.9 Mn by 2030.

 Get Sample Copy of Report _at_ https//www.persisten
cemarketresearch.com/samples/2983
4
Market Segmentation
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/2983
5
(No Transcript)